310.07 USD
▲-2.32+1.49%
盘后 311.56 +1.98%
2026-08-03
市值
$8.64B
市盈率
—
EPS
-13.35
股息率
—
52 周区间
37.19 – 366.52
成交量
301.89K
Beta
2.76
目标价
610.05
52W 低 37.1952W 高 366.52
价格走势
公司简介
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States. The company’s platforms include Cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and Solidus to discover and develop antisense oligonucleotide. It also develops ulixacaltamide, a small molecule inhibitor of T-type calcium channels that in N...